BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prague JK. Neurokinin 3 receptor antagonists - prime time? Climacteric 2021;24:25-31. [PMID: 33135940 DOI: 10.1080/13697137.2020.1834530] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Gilmore KL, Mansour D. A case vignette describing management of menopausal symptoms and migraine in the perimenopause. BMJ Sex Reprod Health 2021:bmjsrh-2020-200977. [PMID: 34732402 DOI: 10.1136/bmjsrh-2020-200977] [Reference Citation Analysis]
2 Menown SJ, Tello JA. Neurokinin 3 Receptor Antagonists Compared With Serotonin Norepinephrine Reuptake Inhibitors for Non-Hormonal Treatment of Menopausal Hot Flushes: A Systematic Qualitative Review. Adv Ther 2021;38:5025-45. [PMID: 34514552 DOI: 10.1007/s12325-021-01900-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Lobo RA, Gompel A. Management of menopause: a view towards prevention. The Lancet Diabetes & Endocrinology 2022;10:457-70. [DOI: 10.1016/s2213-8587(21)00269-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Anderson RC, Hanyroup S, Song YB, Mohamed-Moosa Z, van den Bout I, Schwulst AC, Kaiser UB, Millar RP, Newton CL. Functional Rescue of Inactivating Mutations of the Human Neurokinin 3 Receptor Using Pharmacological Chaperones. Int J Mol Sci 2022;23:4587. [PMID: 35562976 DOI: 10.3390/ijms23094587] [Reference Citation Analysis]